This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeeting. This question was inspired by the session "Rheumatoid Arthritis-Associated Interstitial Lung Disease: Advances in Screening, Diagnosis and Patient Phenotyping" by Dr. Scott Matson, Dr. Bryant England, and Dr. Vanessa Smith.
I have started screening all new patients with RA ...